Treating ischaemic stroke with intravenous tPA beyond 4.5 hours under the guidance of a MRI DWI/T2WI mismatch was safe and effective

PURPOSE: Clinical trials have provided evidence that treating patients with acute ischaemic stroke (AIS) beyond 4.5 hours was feasible. Among them using MRI diffusion-weighted imaging/fluid attenuation inversion response (DWI/FLAIR) mismatch to guide intravenous tissue plasminogen activator (tPA) wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Bai, Qing-ke, Zhao, Zhen-guo, Lu, Lian-jun, Shen, Jian, Zhang, Jian-ying, Sui, Hai-jing, Xie, Xiu-hai, Chen, Juan, Yang, Juan, Chen, Cui-rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475081/
https://www.ncbi.nlm.nih.gov/pubmed/31105973
http://dx.doi.org/10.1136/svn-2018-000186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475081/
https://www.ncbi.nlm.nih.gov/pubmed/31105973
http://dx.doi.org/10.1136/svn-2018-000186

Ejemplares similares